Quantcast
Channel: Veterinary Medicines Directorate - Activity on GOV.UK
Viewing all 1504 articles
Browse latest View live

News story: VMD announces the new Director of Authorisations: Abigal Seager

$
0
0

The VMD is pleased to announce that the new Director of the Authorisations Division is Abigail Seager who will take up her position on 1 May 2018.

Since 2016 Abigail has been Head of the EU Exit and International Office at the VMD. Before this, from 2006, she was Head of the General Assessment and Imports Team. Her previous roles include: Deputy Head of Fisheries Legislation (Defra), where she led on the establishment of the Marine Fisheries Agency (2004-6), and Senior Policy Officer in the Criminal Justice Fine Enforcement team, Ministry of Justice, where she took the new policy on fine enforcement through to primary legislation (Courts Act Bill) and implementation of the new legislation (2002-4).


Detailed guide: Report a product defect: veterinary medicine

$
0
0

Updated: Updated Product Defect Report form

Reporting a product defect

If a pharmaceutical company becomes aware of an issue or defect with one of their products or a batch of product they must report this to the Veterinary Medicines Directorate (VMD).

Complete the Product defect report form (MS Word Document, 49KB) and send it to rapidalert@vmd.defra.gsi.gov.uk.

If the product or batch is likely to be recalled due to the defect you must contact the VMD to discuss the issue. Where appropriate give details of the level of recall, e.g. wholesaler level, veterinary practice level.

Do not use this form to report an adverse event to a veterinary medicine or microchip; To report a suspected adverse event.

List of recalled products

Products recalled in the UK in the last 12 months.

Notification DateProductBatch No.Problem
09 March 2018Oxytobel 10 IU/ml Solution for InjectionJ2101-03There is a potential for decreased levels of the preservative Chlorobutanol hemihydrate in the affected batch.
16 February 2018Ornicure 150mg/g doxycycline powder for oral solution16L16 741 16L19 742 16L15 739Damage to 200g packages found during stability testing.
26 September 2017Meloxaid 5mg/ml Solution for Injection6094-93B 6094-94MAn OOS for pH was identified for the product during the sampling and analysis programme.
24 May 2017Flypor 4% w/v Pour-on SolutionC681480Some units in this batch have been reported to be leaking a small amount of product from around the cap due to the induction heat seals in some packs not being completely sealed to the bottle.
19 April 2017Deosect 5% w/v Concentrate for Cutaneous Spray SolutionE16140, E16178, E16162Aluminium foil seal appears to be defective resulting in slight leakage of the product during storage.
10 April 2017Cefshot DC 250mg Intramammary Suspension for CattleABE031A, ALS018AZoetis UK Ltd has identified that there is a small possibility that some syringes from the batches listed, have not been correctly sterilised.
07 February 2017Propofol Emulsion for Injection 1.0% w/vAll productsAn issue of coring has been reported, where the shearing off of a portion of the 20mm bromobutyl bung occurs as the vial is pierced to withdraw the product. This may result in particles from the bung entering the product. It may also result in the bung not resealing fully after use.

What issues are classed as a product defect?

These would include:

  • incorrect labelling (e.g. product strength, name of ingredients)
  • misinformation or lack of information on the packaging or leaflets
  • incorrect manufacture (e.g. strength of the ingredients or an issue with the container)
  • contamination of any kind
  • stability (e.g. expiry)
  • counterfeit or deliberately tampered with product

Further information on how VMD handles product defect reports can be found in Analysis of reports received by the VMD in 2016-17 (PDF, 244KB, 7 pages) .

The holder of an authorisation referred to in Article 44 of Directive 2001/82/EC (for veterinary products) is required by Article 13 of Directive 91/412/EEC (for veterinary products) to implement an effective procedure for the recall of defective products. The authorisation holder is required to notify the relevant Competent Authority of any defect that could result in a recall and indicate, as far as possible, the countries of destination of the defective product.

For information on human medicines please visit the MHRA Safety Information page.

Contact

rapidalert@vmd.defra.gsi.gov.uk

Alternatively phone the Inspections team via the switchboard on, 01932 336911.

News story: Alvegesic vet. 10 mg/ml Solution for injection for Horses, Dogs and Cats - Product defect recall alert

$
0
0

We wish to make wholesalers and veterinarians aware that Alvetra u. Werfft GmbH has issued a batch recall of Alvegesic vet. 10 mg/ml Solution for injection for Horses, Dogs and Cats (Vm 32802/4000) due to contamination during production.

The following batch is affected:

  • Product: Alvegesic vet. 10mg/ml, 10mI - Batch No. PO0545 EXPIRY: 03-2019

For further information regarding the recall, please contact Mette Thulstrup Bruhn: mette.bruhn@dechra.com

News story: VMD survey: The Disposal of Controlled Drugs

$
0
0

The VMD is carrying out a survey on the disposal of controlled drugs. Our aim is to understand the extent of the problem vets face when getting controlled drugs witnessed for disposal.

At present vets must destroy schedule 2 controlled drugs in the presence of and directed by any of the following:

  • an inspector appointed under the Veterinary Medicines Regulations
  • a vet, independent of the practice where the destruction takes place
  • a person legally authorised to witness the destruction of CD such as a Police CD Liaison Officer (CDLO)

We note that there is a shortage of Police CDLOs, alongside inspectors not being in the area and no independent vets within close proximity, therefore have commissioned this survey.

By answering the survey, you will help the VMD establish the extent of this problem around the UK and inform any future possible policy development.

The survey is open until 6 June 2018, is voluntary and open to all UK registered vets. It should not take any longer than 15 minutes to complete. Please note no personal data is being collected, however all data will be treated in accordance with the Data Protection Act. Published data will be anonymised and aggregated.

The VMD legislation team is responsible for conducting this survey and can be contacted on 01932 338316 or controlleddrugssurvey@vmd.defra.gsi.gov.uk

The VMD would like to thank you for taking the time to complete this survey, further guidence on controlled drugs is available.

Official Statistics: VMD Published Standards 2018 to 2019: Monitoring Performance

News story: Animal medicines seizure notice: Aquatic Chemicals Ltd (trading as Technical Aquatic Products (TAP))

$
0
0

Approximately 2,000 products, which equates to around 1,250 litres, were seized as unauthorised veterinary medicines.

These products were intended for the aquarium and pond fish market. The products had not been manufactured by a holder of a manufacturing authorisation.

The sale and supply of these products is an offence under Regulation 4 (Placing a veterinary medicinal product on the market), Regulation 26 (Possession of an unauthorised veterinary medicinal product) and Schedule 3, Regulation 27 (Supply of an unauthorised veterinary medicinal product) of the Veterinary Medicines Regulations.

Supply problem with Equip EHV1,4

$
0
0
The VMD has been made aware of supply problem with Equip EHV1,4 Vm 00057/4316.

New online Export Certificates Site

$
0
0
New online Export Certificates Site.

Invitation to debate 'Regulating internet pharmacies - fist or feather'

$
0
0
Invitation to debate 'Regulating internet pharmacies - fist or feather' by the Chartered Institute of Marketing 30 April 2013.

Exercise to appoint two new members to the VPC

$
0
0
Exercise to appoint two new members to the VPC.

Reduced Fees for Specific Batch Control Requests

$
0
0
Reduced Fees for Specific Batch Control Requests.

Cessation of the Partnership Initiative

$
0
0
The partnership initiative will soon cease to be valid, because the scope of the variation regulations will be extended to include products authorised on a national only basis on 4th August 2013.

MAVIS 86 Published

Fees Charged for Changes to Distributor Details

$
0
0
The VMD has reviewed the fees charged for changes to distributor details that arise as a consequence of changes to Marketing Authorisation Holder (MAH) details.

A Statement to Clarify the Position On the Use of Chlortetracycline in Calf Milk Replacer

$
0
0
A Statement to Clarify the Position On the Use of Chlortetracycline in Calf Milk Replacer.

Summary of responses to the Veterinary Medicines Regulations 2013 Formal Public Consultation

$
0
0
Summary of responses to the Veterinary Medicines Regulations 2013 Formal Public Consultation.

Survey of veterinary surgeons' prescribing practices under the 'cascade' - Closes 12 July 2013

$
0
0
Survey of veterinary surgeons' prescribing practices under the 'cascade' - Closes 12 July 2013.

The VMD Authorises Schmallenberg Vaccine

$
0
0
UK farmers will be the first in the EU with access to a vaccine to help protect sheep and cattle against birth defects caused by the Schmallenberg Virus (SBV).

Presentations from Industry Information Day

$
0
0
Presentations from Industry Information Day held on 14 May 2013.

Summary of UK Veterinary Prescribing Pressures Focus Groups

$
0
0
Summary of UK Veterinary Prescribing Pressures Focus Groups.
Viewing all 1504 articles
Browse latest View live




Latest Images